DND Technologies, Inc. (DNDT)

USD 0.04

(0.0%)

Market Cap (In USD)

114.23 Thousand

Revenue (In USD)

-

Net Income (In USD)

-76.66 Thousand

Avg. Volume

101.00

Currency
USD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0279-0.088
PE
-
EPS
-
Beta Value
-2.688
ISIN
US23325K2042
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Beverages - Non-Alcoholic
CEO
Mr. Christopher C. Corwin
Employee Count
-
Website
-
Ipo Date
2013-01-16
Details
DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.

More Stocks